News

Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA.

Could AI be the key to curing cancer? Meet the leader of a new research team putting that question to the test.

The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.

It was 84 years ago this week that UT researchers isolated and named folic acid.

Bryan Davies, a professor in the Department of Molecular Biosciences, and a team have identified antibodies that offer a direct hit on dangerous bacteria.

Stengl-Wyer Endowment-supported researchers and research at UT Austin will explore life in a variety of forms and environments.

With support from the Cancer Prevention and Research Institute of Texas, molecular bioscientist Dima Kozakov joins UT.

UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences.

University of Texas at Austin researchers have developed a new method to encode information in synthetic molecules.